Top Sell
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €36.81 | €70.67 | 91.998% |
| Exelon Corp. | 8 | 3 | 0 | 0 | €31.63 | €39.50 | 24.895% |
| Medtronic plc | 7 | 3 | 0 | 1 | €70.93 | €90.60 | 27.733% |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | €26.40 | €34.68 | 31.358% |
| CVR Energy Inc. | 1 | 3 | 0 | 1 | €23.39 | €24.77 | 5.906% |
| DXC Technology Co | 0 | 3 | 0 | 0 | €17.33 | - | - |
| Appian | 10 | 3 | 0 | 0 | €29.53 | €41.30 | 39.846% |
| Xcel Energy Inc. | 8 | 3 | 0 | 0 | €48.13 | €56.61 | 17.628% |
| CF Industries Holdings Inc. | 9 | 3 | 0 | 0 | €64.09 | €89.17 | 39.128% |
| BASF SE ADR | 2 | 3 | 1 | 0 | €11.00 | - | - |
| Lithia Motors Inc. A | 6 | 3 | 1 | 0 | €230.00 | €319.06 | 38.723% |
| Renasant Corp. | 0 | 3 | 0 | 0 | €27.00 | - | - |
| ASGN Inc. | 6 | 3 | 0 | 0 | €80.00 | €96.71 | 20.889% |
| Glycomimetics Inc. | 5 | 3 | 0 | 3 | €0.26 | €7.35 | 2777.339% |
| Akebia Therapeutics Inc. | 7 | 3 | 0 | 1 | €0.87 | €3.60 | 312.741% |
| Weibo Corp. ADR | 3 | 3 | 0 | 0 | €7.50 | €10.59 | 41.236% |
| Adient PLC | 7 | 3 | 1 | 0 | €22.20 | €37.72 | 69.904% |
| eXp World Holdings | 0 | 3 | 0 | 0 | €10.45 | €10.95 | 4.822% |
| Prospect Capital Corp. | 0 | 3 | 0 | 0 | €5.15 | €4.96 | -3.711% |
| NIO Inc. ADR | 5 | 3 | 1 | 0 | €4.22 | €7.80 | 84.846% |
| Westamerica Bancorp. | 0 | 3 | 0 | 1 | €43.60 | - | - |
| Novagold Resources | 0 | 3 | 0 | 0 | €3.46 | - | - |
| Diageo plc ADR | 1 | 3 | 1 | 0 | €117.00 | - | - |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.06 | €5.00 | 143.309% |
| B + G Foods | 0 | 4 | 0 | 0 | €7.23 | - | - |